Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1073 of 5804
-
New smart chemo targets tumors, spares healthy tissue
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients with locally advanced (unresectable) or metastatic solid tumors that are likely to be FAP positive. The study consists of…
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for ulcerative colitis sufferers: drug trial launches
Disease control Not yet recruitingThis study will evaluate the efficacy and safety of 627 in patients with UC.
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can immune cells revive lung cancer treatment?
Disease control Not yet recruitingThis is a single-arm study designed to evaluate the safety and efficacy of TILs combined with third-generation EGFR-TKIs therapy for patients with EGFR-mutant NSCLC resistant to TKI.
Phase: EARLY_PHASE1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New device aims to seal brain aneurysms without surgery
Disease control Not yet recruitingThe objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery …
Phase: NA • Sponsor: World Medica USA, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New chemo delivery method aims to shrink untreatable colon tumors
Disease control Recruiting nowThis is a prospective, multicenter, randomized, and open-label clinical trial. It is initiated to determine the efficacy of FOLFOX-based, transarterial infusion chemotherapy (TAIC) combined with either cetuximab or bevacizumab for patients with unresectable colorectal cancer (CRC…
Phase: NA • Sponsor: Quanda Liu • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Ancient herbal mix may shorten radiation mouth pain in cancer patients
Symptom relief Recruiting nowEvaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New gel could boost recovery after sinus surgery
Disease control Not yet recruitingEndoscopic sinus surgery (ESS) is commonly performed in patients with chronic rhinosinusitis (CRS) to improve sinus drainage and allow better delivery of topical therapies after surgery. Despite surgery, postoperative inflammation can persist and negatively affect healing and out…
Phase: PHASE3 • Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Sickle cell drug pociredir tested for Long-Term safety in 50 patients
Disease control ENROLLING_BY_INVITATIONThis is an open-label study to evaluate the safety and tolerability of long-term treatment with pociredir without a comparator in participants with SCD who have previously been treated and shown benefit with pociredir in feeder study 6058-SCD-101 (NCT05169580). Participants in th…
Phase: PHASE2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could steroids save your joints after a severe infection?
Disease control Not yet recruitingSeptic arthritis is a severe infection associated with significant morbidity and mortality. Despite eradication of the microorganisms, persistent inflammation may lead to substantial long-term functional joint sequelae. The use of corticosteroids could reduce this inflammation, t…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New heart ablation study targets health disparities in minorities
Disease control Recruiting nowThis pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected wi…
Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug cocktail aims to tackle tough skin cancer
Disease control Not yet recruitingCutaneous T-cell lymphomas (CTCL) are a rare and heterogeneous group of extranidal T-cell lymphomas characterized by skin involvement. Current treatment options for CTCL are limited. Although responses have been demonstrated, their duration is often short, especially in patients …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New chemo cocktail aims to treat rare lymphoma without heart damage
Disease control Not yet recruitingPeripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare disorders that result from clonal proliferation of mature post-thymic lymphocytes. These T-cell neoplasms account for approximately 10-15% of all lymphomas. The most common subtype of PTCL is classified as "not…
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New camera system spots hidden signs of awareness in brain injury patients
Knowledge-focused Recruiting nowObjective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments,…
Phase: NA • Sponsor: Stony Brook University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to shield young female soccer stars from devastating knee injuries
Prevention Not yet recruitingAnterior cruciate ligament (ACL) injuries are common in female soccer and frequently occur during change-of-direction (COD) movements without contact. Biomechanical deficits during these movements are considered important risk factors. This study aims to evaluate the effects of …
Phase: NA • Sponsor: University of Liege • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Light therapy and donor cells aim to stop kidney rejection
Disease control Not yet recruitingThis is a phase 1 trial, 36 month duration for subjects with end-stage renal disease (ESRD). The objectives of the trail are1) Determine the safety of ECP-DL cell infusion in living donor renal transplant recipients. 2) Determine rates of graft rejection and compare to historical…
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Diabetes meds boost pregnancy chances in PCOS women
Disease control CompletedThe aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.
Phase: PHASE3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New trial: can hormone pills boost targeted cancer therapy?
Disease control Recruiting nowThe goal of this study is to determine whether the addition of Androgen Deprivation Therapy (ADT) utilizing the study drug ELIGARD® to Recurrence- Directed Therapy (RDT) improves progression-free survival (PFS) compared to RDT alone in patients with early radio-recurrent oligo-me…
Phase: PHASE2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New scan could catch breast cancer spread that standard tests miss
Diagnosis Not yet recruitingInvasive squamous cell carcinoma (ISCC) represents 5 to 15% of breast cancers. Despite the rarity of this pathology, the number of patients with Invasive squamous cell carcinoma treated at HCL is significant. Patients at risk of metastasis are usually referred to the HCL Nuclear…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could a High-Tech suit help MS patients walk better?
Symptom relief Recruiting nowThe EXOPULSE Suit is a medical device composed of 50 electrodes capable of stimulating up to 43 major muscle groups throughout the body. The multisite electrical stimulation relaxes tense and spastic muscles, thereby enhancing mobility and balance. This non-invasive body garment …
Phase: NA • Sponsor: Otto Bock France SNC • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New device aims to ease heart failure symptoms by stimulating blood pressure sensors
Disease control Recruiting nowThis study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to as…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC